tradingkey.logo

Mangoceuticals Inc

MGRX
1.800USD
0.000
Close 11/05, 16:00ETQuotes delayed by 15 min
19.16MMarket Cap
LossP/E TTM

Mangoceuticals Inc

1.800
0.000

More Details of Mangoceuticals Inc Company

Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.

Mangoceuticals Inc Info

Ticker SymbolMGRX
Company nameMangoceuticals Inc
IPO dateMar 21, 2023
CEOMr. Jacob D. Cohen
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMar 21
Address15110 Dallas Pkwy, Suite 600
CityDALLAS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code75248
Phone18336264679
Websitehttps://www.mangorx.com/
Ticker SymbolMGRX
IPO dateMar 21, 2023
CEOMr. Jacob D. Cohen

Company Executives of Mangoceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
138.33K
+260.87%
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
126.67K
+375.00%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
138.33K
+260.87%
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
+272.72%
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
126.67K
+375.00%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Revenue Breakdown

No Data
No Data
By Business
By Region
No Data

Shareholding Stats

Updated: Sat, Sep 6
Updated: Sat, Sep 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cohen (Jacob D.)
9.56%
Navy Wharf, Ltd.
7.32%
Propre Energie Inc
4.76%
Greenfield Investments Ltd
3.77%
The Vanguard Group, Inc.
1.34%
Other
73.25%
Shareholders
Shareholders
Proportion
Cohen (Jacob D.)
9.56%
Navy Wharf, Ltd.
7.32%
Propre Energie Inc
4.76%
Greenfield Investments Ltd
3.77%
The Vanguard Group, Inc.
1.34%
Other
73.25%
Shareholder Types
Shareholders
Proportion
Corporation
15.85%
Individual Investor
14.02%
Investment Advisor
1.63%
Hedge Fund
0.24%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.08%
Other
67.98%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
27
292.25K
2.14%
+144.27K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
2023Q3
19
652.27K
63.81%
+112.43K
2023Q2
12
649.40K
63.58%
+115.75K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Cohen (Jacob D.)
1.30M
12.39%
+500.00K
+62.11%
Jul 21, 2025
Navy Wharf, Ltd.
1.00M
9.49%
+1.00M
--
May 27, 2025
Propre Energie Inc
650.00K
6.17%
--
--
May 27, 2025
Greenfield Investments Ltd
515.00K
4.89%
--
--
May 27, 2025
The Vanguard Group, Inc.
182.61K
1.73%
+182.61K
--
Jun 30, 2025
Johnston (Eugene M)
138.33K
1.31%
+100.00K
+260.87%
Sep 09, 2025
Myers (Kenny)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
D'Alessio (Lorraine Pamela)
136.67K
1.3%
+100.00K
+272.72%
Sep 09, 2025
Hamilton (Alex P)
126.67K
1.2%
+100.00K
+375.00%
Sep 09, 2025
Isaac (Antonios)
60.00K
0.57%
--
--
May 27, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Date
Type
Ratio
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
KeyAI